Shinya Sato

11PUBLICATIONS
17CO-AUTHORS
Traditional Chinese medicine and treatmentsMedical infection agents (incl. prions)ClinimetricsMetabolic medicineCondensed matter characterisation technique development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 13, 2026
Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710.

|Jul 28, 2026
Bovine Milk-Derived Extracellular Vesicles Ameliorate Steatohepatitis by Restoring Gut Barrier in CDA-HFD-Fed Mice.

|Feb 27, 2026
Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response.

Aritoshi Koizumi, Tadashi Namisaki, Akihiko Shibamoto

|Dec 30, 2025
Diabetes as a Risk Factor for Sarcopenia in Patients with MASH-Related Cirrhosis.

Shinya Sato, Hiroaki Takaya, Tadashi Namisaki

|Oct 16, 2025
Creatinine-to-Cystatin C Ratio Combined with FIB-4 and ELF for Noninvasive Fibrosis Assessment in MASLD.

Masafumi Oyama, Tadashi Namisaki, Akihiko Shibamoto

|Sep 13, 2025
Efficacy of an Endoscopic Device Integrating a Sphincterotome and a Dilation Balloon Catheter for the Treatment of Choledocholithiasis (with Video).

Jun-Ichi Hanatani, Koh Kitagawa, Shohei Asada

Pageof 2

Frequent Collaborators

11 joint publications

Tadashi Namisaki

9 joint publications

Norihisa Nishimura

9 joint publications

Koh Kitagawa

5 joint publications

Satoshi Iwai